MedPath

EPIGRANEX CAPSULES

Registration Number: MAL19036042N

Approved
Approval ID

0d02d36ce6f72815

Registration Number

MAL19036042N

Registration Date

Jul 4, 2025

Regulatory Authority
NPRA
Malaysia

Product Information

Additional product specifications and packaging information as registered with NPRA Malaysia.

Product Specifications

PRODUCT SPECIFICATIONS

Official SourceNPRA Database
Available Package Types4 types
Last UpdatedJul 4, 2025

PACKAGING INFORMATION (4)

14 CapsulesAvailable
Package Size: 14 Capsules
Status: NPRA Approved
30 CapsulesAvailable
Package Size: 30 Capsules
Status: NPRA Approved
60 CapsulesAvailable
Package Size: 60 Capsules
Status: NPRA Approved
90 CapsulesAvailable
Package Size: 90 Capsules
Status: NPRA Approved

Active Ingredients

Active pharmaceutical ingredients contained in this NPRA-approved product.

Ingredients (7)

BROMELAINActive
Monograph: 菠萝蛋白酶
Retinyl Acetate (Vitamin A)Active
Monograph: retinyl acetate (vitamin a)
ZINC GLUCONATEActive
Monograph: 葡萄糖酸锌
SELENIUM YEASTActive
Monograph: Selenious acid
CHROMIUM YEASTActive
Monograph: chromium yeast
ASCORBIC ACID (VITAMIN C)Active
Monograph: ascorbic acid (vitamin c)
L-ARGININEActive
Monograph: L-arginine

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

EPIGRANEX CAPSULES - NPRA Drug Approval Details | MedPath - Medical Intelligence Platform